Clinical outcomes based on multigene profiling in metastatic breast cancer patients

BACKGROUND: Identifying the clinical impact of recurrent mutations can help define their role in cancer. Here, we identify frequent hotspot mutations in metastatic breast cancer (MBC) patients and associate them with clinical outcomes. PATIENTS AND METHODS: Hotspot mutation testing was conducted in...

Descripción completa

Detalles Bibliográficos
Autores principales: Basho, Reva K., de Melo Gagliato, Debora, Ueno, Naoto T., Wathoo, Chetna, Chen, Huiqin, Shariati, Maryam, Wei, Caimiao, Alvarez, Ricardo H., Moulder, Stacy L., Sahin, Aysegul A., Roy-Chowdhuri, Sinchita, Chavez-MacGregor, Mariana, Litton, Jennifer K., Valero, Vincent, Luthra, Raja, Zeng, Jia, Shaw, Kenna R., Mendelsohn, John, Mills, Gordon B., Tripathy, Debu, Meric-Bernstam, Funda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Priority Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363515/
https://www.ncbi.nlm.nih.gov/pubmed/27806348
http://dx.doi.org/10.18632/oncotarget.12987

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363515/
https://www.ncbi.nlm.nih.gov/pubmed/27806348
http://dx.doi.org/10.18632/oncotarget.12987

Ejemplares similares